(Q52879885)

9 May 2018

title

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients. (English)

1 reference

9 May 2018

1 reference

metastatic colon cancer

1 reference

1 reference

J Vidal

1

1 reference

9 May 2018

L Muinelo

2

1 reference

9 May 2018

A Dalmases

3

1 reference

9 May 2018

F Jones

4

1 reference

9 May 2018

D Edelstein

5

1 reference

9 May 2018

M Iglesias

6

1 reference

9 May 2018

M Orrillo

7

1 reference

9 May 2018

A Abalo

8

1 reference

9 May 2018

C Rodríguez

9

1 reference

9 May 2018

E Brozos

10

1 reference

9 May 2018

Y Vidal

11

1 reference

9 May 2018

S Candamio

12

1 reference

9 May 2018

F Vázquez

13

1 reference

9 May 2018

J Ruiz

14

1 reference

9 May 2018

M Guix

15

1 reference

9 May 2018

L Visa

16

1 reference

9 May 2018

V Sikri

17

1 reference

9 May 2018

J Albanell

18

1 reference

9 May 2018

B Bellosillo

19

1 reference

9 May 2018

R López

20

1 reference

9 May 2018

C Montagut

21

1 reference

9 May 2018

publication date

13 April 2017

1 reference

9 May 2018

published in

Annals of Oncology

1 reference

9 May 2018

volume

28

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

1325-1332

1 reference

9 May 2018

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Detection of circulating tumor DNA in early- and late-stage human malignancies

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

Circulating mutant DNA to assess tumor dynamics

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5834035

13 August 2018

Identifiers

DOI

10.1093/ANNONC/MDX125

1 reference

9 May 2018

PMCID

5834035

1 reference

9 May 2018

PubMed ID

28419195

1 reference

9 May 2018